E
BioNTech SE BNTX
$105.07 -$5.81-5.24% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -0.27% -258.18% 27.01% 125.05% -154.18%
Total Depreciation and Amortization 28.51% -74.45% 261.20% -9.12% 29.18%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -772.82% 104.43% 7.84% -1,185.11% 107.31%
Change in Net Operating Assets 239.05% 40.61% 0.60% -129.16% 954.18%
Cash from Operations 120.24% -66.36% 29.69% -140.10% 608.46%
Capital Expenditure 40.23% 27.51% 11.30% 16.07% -50.16%
Sale of Property, Plant, and Equipment 7.85% -29.48% 126.26% 53.18% --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -102.97% 101.63% 1,037.01% 53.54% 93.25%
Cash from Investing -105.57% 102.88% 513.98% 39.87% 89.61%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 3.62% -89.04% 7.59% 65.50% -193.59%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -3.94% -86.62% 10.40% 64.76% -191.09%
Foreign Exchange rate Adjustments 161.63% -216.87% 673.33% 28.81% -148.12%
Miscellaneous Cash Flow Adjustments 153.92% -5.09% -130.75% -1.39% 162.35%
Net Change in Cash -78.43% 204.15% 117.70% -154.87% 151.66%